These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2516173)

  • 1. Enzymological characterization of a feline analogue of primary hyperoxaluria type 2: a model for the human disease.
    Danpure CJ; Jennings PR; Mistry J; Chalmers RA; McKerrell RE; Blakemore WF; Heath MF
    J Inherit Metab Dis; 1989; 12(4):403-14. PubMed ID: 2516173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymological characterization of a putative canine analogue of primary hyperoxaluria type 1.
    Danpure CJ; Jennings PR; Jansen JH
    Biochim Biophys Acta; 1991 Feb; 1096(2):134-8. PubMed ID: 1672096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.
    Cramer SD; Ferree PM; Lin K; Milliner DS; Holmes RP
    Hum Mol Genet; 1999 Oct; 8(11):2063-9. PubMed ID: 10484776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperoxaluria type 2: enzymology.
    Giafi CF; Rumsby G
    J Nephrol; 1998; 11 Suppl 1():29-31. PubMed ID: 9604806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2.
    Giafi CF; Rumsby G
    Ann Clin Biochem; 1998 Jan; 35 ( Pt 1)():104-9. PubMed ID: 9463747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme specificity of mammalian liver D-glycerate dehydrogenase.
    Van Schaftingen E; Draye JP; Van Hoof F
    Eur J Biochem; 1989 Dec; 186(1-2):355-9. PubMed ID: 2689175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperoxaluria type 2.
    Mansell MA
    Nephrol Dial Transplant; 1995; 10 Suppl 8():58-60. PubMed ID: 8592629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
    Danpure CJ; Jennings PR
    Clin Sci (Lond); 1988 Sep; 75(3):315-22. PubMed ID: 3416563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE OXIDATION OF D- AND L-GLYCERATE BY RAT LIVER.
    DAWKINS PD; DICKENS F
    Biochem J; 1965 Feb; 94(2):353-67. PubMed ID: 14346088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.
    Knight J; Holmes RP; Milliner DS; Monico CG; Cramer SD
    Nephrol Dial Transplant; 2006 Aug; 21(8):2292-5. PubMed ID: 16597637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity.
    Danpure CJ; Jennings PR; Watts RW
    Lancet; 1987 Feb; 1(8528):289-91. PubMed ID: 2880111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological heterogeneity of hepatic alanine:glyoxylate aminotransferase in primary hyperoxaluria type 1.
    Wise PJ; Danpure CJ; Jennings PR
    FEBS Lett; 1987 Sep; 222(1):17-20. PubMed ID: 2443389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.
    Konkoľová J; Chandoga J; Kováčik J; Repiský M; Kramarová V; Paučinová I; Böhmer D
    BMC Med Genet; 2017 May; 18(1):59. PubMed ID: 28569194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in our understanding of primary hyperoxaluria type 2.
    Cregeen DP; Rumsby G
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S348-50. PubMed ID: 10541261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary hyperoxaluria].
    De Pauw L; Toussaint C
    Rev Med Brux; 1996 Apr; 17(2):67-74. PubMed ID: 8685551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human liver L-alanine-glyoxylate aminotransferase: characteristics and activity in controls and hyperoxaluria type I patients using a simple spectrophotometric method.
    Wanders RJ; Ruiter J; van Roermund CW; Schutgens RB; Ofman R; Jurriaans S; Tager JM
    Clin Chim Acta; 1990 Aug; 189(2):139-44. PubMed ID: 2397596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and expression of a cDNA for human hydroxypyruvate/glyoxylate reductase.
    Rumsby G; Cregeen DP
    Biochim Biophys Acta; 1999 Sep; 1446(3):383-8. PubMed ID: 10524214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation.
    Purdue PE; Allsop J; Isaya G; Rosenberg LE; Danpure CJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10900-4. PubMed ID: 1961759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
    Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
    Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1.
    Cooper PJ; Danpure CJ; Wise PJ; Guttridge KM
    J Histochem Cytochem; 1988 Oct; 36(10):1285-94. PubMed ID: 3418107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.